- Home
- EPM vs PBYI Comparison
EPM vs PBYI Comparison
Compare EPM & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPM
- PBYI
- Stock Information
- Founded
- EPM 2003
- PBYI 2010
- Country
- EPM United States
- PBYI United States
- Employees
- EPM N/A
- PBYI N/A
- Industry
- EPM Oil & Gas Production
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- EPM Energy
- PBYI Health Care
- Exchange
- EPM Nasdaq
- PBYI Nasdaq
- Market Cap
- EPM 164.3M
- PBYI 171.7M
- IPO Year
- EPM 1996
- PBYI N/A
- Fundamental
- Price
- EPM $5.06
- PBYI $3.28
- Analyst Decision
- EPM Hold
- PBYI Strong Buy
- Analyst Count
- EPM 1
- PBYI 1
- Target Price
- EPM $4.50
- PBYI $7.00
- AVG Volume (30 Days)
- EPM 208.8K
- PBYI 351.2K
- Earning Date
- EPM 09-09-2025
- PBYI 08-07-2025
- Dividend Yield
- EPM 9.49%
- PBYI N/A
- EPS Growth
- EPM N/A
- PBYI 143.51
- EPS
- EPM N/A
- PBYI 0.77
- Revenue
- EPM $85,959,000.00
- PBYI $232,709,000.00
- Revenue This Year
- EPM $2.62
- PBYI N/A
- Revenue Next Year
- EPM $4.53
- PBYI N/A
- P/E Ratio
- EPM N/A
- PBYI $4.25
- Revenue Growth
- EPM 3.79
- PBYI 2.68
- 52 Week Low
- EPM $4.05
- PBYI $2.23
- 52 Week High
- EPM $6.14
- PBYI $4.13
- Technical
- Relative Strength Index (RSI)
- EPM 61.46
- PBYI 40.98
- Support Level
- EPM $4.69
- PBYI $3.34
- Resistance Level
- EPM $4.85
- PBYI $3.55
- Average True Range (ATR)
- EPM 0.12
- PBYI 0.13
- MACD
- EPM 0.02
- PBYI -0.02
- Stochastic Oscillator
- EPM 93.59
- PBYI 11.11
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent oil and gas company operating in the United States. It is engaged predominantly in the acquisition, exploitation, and development of properties for the production of crude oil and natural gas, onshore in the United States. The company's revenues are generated from its crude oil, natural gas, and NGL production from the Jonah Field in Sublette County, Wyoming; the Williston Basin in North Dakota; the Barnett Shale located in North Texas; the Hamilton Dome Field in Wyoming; and the Delhi Field in Northeast Louisiana.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.